Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- AO Innovation Translation Center
- Study ID
- NCT04098146
- Status
- Recruiting
Conditions
- Mandibular Reconstruction
- Segmental Mandibular Defects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Surgical Resection and Reconstruction — PROCEDUREOne stage reconstruction: Osseous reconstruction is performed in the same surgery of the tumor/mandibular resection. It is also known as immediate or primary reconstruction. Second stage reconstruction: Osseous reconstruction is performed after the tumor/mandibular resection surgery as an independent surgery. After the mandibular resection a temporary alloplastic bridging might be put in place. It is also known as delayed or secondary reconstruction.
Study Details
Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.
Key Dates
- Start date
- Sep 12, 2022
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Mandibular ReconstructionPatients undergoing segmental mandibular defect reconstruction. The decision of one stage or two stage reconstruction is done according to the patient and treating surgeon preferences following the local standard of care
Primary Outcome Measure
Demographics [ Time Frame: Baseline until resection surgery approximately 4 weeks ]
Central Contacts
- Maria Medina Giner0795456120
- Marco Minoia, PhD
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Florida College of Medicine | Jacksonville | Florida | 32209 | |
| University of Illinois Chicago | Chicago | Illinois | 60612 | Nicolas Callahan, MD |
| Northwell Health Cancer Institute | New Hyde Park | New York | 11042 | Brett Miles (PRINCIPAL_INVESTIGATOR) Danielle Scarola (SUB_INVESTIGATOR) |
| Mount Sinai Hospital | New York | New York | 10029 | Mohammed Khan, MD |
| John Peter Smith Health Network | Fort Worth | Texas | 76104 |